Explore

This article explores strategies that can help address challenges faced by men who are in the initial stages of learning to use intermittent catheterisation.

This study provides valuable insights into the experiences of individuals undergoing IC that optimise patient care and support.

In this publication highlight you can read about the identification, assessment, and treatment of urinary incontinence and bowel control issues.

Recurrent UTIs in children with neurogenic bladders constitute high risk of leading to severe kidney damage and need to be an area of attention. This study is useful in determining treatments and proactive measures for preventing recurrent UTIs.

Ortega et al conducted this retrospective study at a pelvic floor disorder center to evaluate the impact of constipation on urogenital symptoms in women. Bowel problems in women are hypothesized to be associated with the presence and severity of urogenital symptoms and linked to pelvic floor dysfunction.

Autonomic dysreflexia (AD) is an episodic uncontrolled elevation of systolic blood pressure sometimes accompanied by bradycardia. If not managed it can lead to cerebral and spinal hemorrhage, seizures and pulmonary edema.

Introduction of a no-touch catheter/technique for intermittent catheterisation seems to be well accepted both by caregivers and patients and it is not necessarily associated with higher costs.

A patient-centric tool to facilitate goal attainment scaling in neurogenic bladder and bowel dysfunction: path to individualization. People with nervous system disorders often experience ...

According to WHO the problem of antimicrobial resistance is so serious that it threatens our modern healthcare system. By 2050 it may cause 10 million deaths or more if we lose our ability to use effective antibiotics.

At Wellspect HealthCare we take our environmental responsibility seriously. We continuously work to minimise the environmental impact related to our products. We ensure that proper materials are used and all applicable production requirements are followed.

For those who cannot empty their bladder the normal way, intermittent catheterisation is the therapy of choice to maintain urethral health. Complications are common but when hydrophilic single-use catheters entered the market, the risks of UTI dropped significantly.

With more than 30 years on the market, LoFric has been used and documented in several ways. In addition to efficiently emptying the bladder, LoFric’s versatile use includes treatment and prevention of recurrent strictures, administration of chemotherapy by bladder instillation, and resolution of rare complications.

Bladder management with intermittent catheterisation is associated with complications. The most severe and common one is UTI. Single-use, hydrophilic-coated catheters lower the risk of UTIs and have been reported as both convenient and the preferred choice for people who rely on intermittent catheterisation as their bladder management.

Catheter associated urinary tract infections (CAUTI) are common in the hospital setting with consequential morbidity and mortality. The risk of bacterial adhesion and invasion of the urinary tract increases with use of an indwelling catheterisation and may be reduced by adopting intermittent catheterisation using hydrophilic single-use catheters.

Patient adherence plays a key role in a successful and cost-effective catheterisation treatment. A patient who feels part of the decision-making, in control of their options and how they work with their lifestyle is more inclined to stick with their therapy and subsequently experience a good clinical outcome.

Urine often has a high concentration of particles and low content of water. This is referred to as high osmolality. Urine osmolality has a direct effect on catheter lubrication and plays an important role for people who use hydrophilic catheters. A catheter with a surface osmolality in balance with urine is key to reducing withdrawal friction.

A lubricated catheter is recommended to reduce damage to the urethra and lower the risk of hematuria which is a common complication. A cross-over study comparing different hydrophilic catheters showed an even lower frequency of hematuria in patients who chose LoFric.

Extensive studies support scientific literature claiming that use of hydrophilic catheters reduce urethral trauma and urinary tract infections. This in turn can minimise the need for antibiotics. Because of these benefits, we now know ...

Single-use hydrophilic catheters were developed in the early eighties to address long-term complications of intermittent catheterisation seen when reusing plastic catheters with add-on lubrication. As reported by Wyndaele and Maes and Perrouin-Verbe et al.

A surprisingly high number of patients reuses catheters intended for single use every day putting them at risk for unnecessary complications. Single use hydrophilic catheters for intermittent catheterisation lower the risk for short and long-term complications and are a convenient and preferred choice for many patients.

A urethral stricture is an abnormal narrowing of the urethra and is often caused by trauma or inflammation. As catheterisation is one cause of strictures, non-traumatic catheterisation technique and catheter material are essential parts in preventing the occurrence of these complications.

Benign prostatic hyperplasia (BPH) is a leading diagnosis among males. Approximately 100,000 men are treated with transurethral prostate (TURP) surgery each year, making it one of the most common surgical procedures in the United States and several other countries.

Available clinical evidence supports the strategy to always consider intermittent catheterisation as the first therapeutic choice, before considering the use of an indwelling catheter. Intermittent catheterisation is the first therapeutic choice and is a safer ...

Bladder instillation is used for local administration of drugs into the bladder. Examples being treatment of interstitial cystitis and cancer. Drugs are delivered via a catheter, and a hydrophilic-coated surface such as that of the LoFric catheters, reduces the risk for trauma associated with instillation therapy.